Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Astellas Pharma Inc.

Market Cap 3,856B 24.08B 20.75B 19.1B 17.92B 33.66B 2,276B 33.99B 226B 88.2B 1,114B 90.36B 88.45B P/E Ratio 2026
15.5x
P/E Ratio 2027 * 11x
Enterprise Value 4,285B 26.75B 23.06B 21.22B 19.91B 37.4B 2,529B 37.77B 251B 98.01B 1,238B 100B 98.28B EV / Sales 2026
2.24x
EV / Sales 2027 * 1.67x
Free-Float
98.88%
Yield 2026
3.1%
Yield 2027 * 3.74%
1 day-0.30%
1 week-0.82%
Current month-5.64%
1 month-8.92%
3 months-8.73%
6 months-1.47%
Current year+0.68%
1 week 12.82
Extreme 12.8175
13.63
1 month 12.82
Extreme 12.8175
14.71
Current year 12.82
Extreme 12.8175
17.35
1 year 9.11
Extreme 9.11
17.35
3 years 8.37
Extreme 8.37
17.35
5 years 8.37
Extreme 8.37
18.46
10 years 8.37
Extreme 8.37
19.4
Manager TitleAgeSince
Chief Executive Officer 63 10/02/2023
Director of Finance/CFO 54 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 63 01/06/2019
Director/Board Member 69 01/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%-0.82% - - 23.93B
-0.32%-1.72%+37.83%+148.79% 1,010B
-2.16%+1.51%+50.01%+43.93% 580B
-2.70%-0.66%+15.97%+63.07% 402B
-1.18%+1.05%+20.91%+18.37% 330B
-1.52%+2.45%+23.73%+33.03% 281B
-1.95%-4.32%+20.15%+12.96% 280B
-0.57%+5.00%-44.67%-48.28% 197B
-1.31%+1.39%+18.74%+53.45% 192B
-0.38%-2.97%+13.02%+57.34% 156B
Average -1.15%+0.02%+17.30%+42.52% 380.97B
Weighted average by Cap. -1.02%-0.16%+26.16%+67.03%

Financials

2026 2027 *
Net sales 2,132B 13.31B 11.47B 10.56B 9.91B 18.61B 1,258B 18.8B 125B 48.77B 616B 49.96B 48.9B 2,244B 14.01B 12.08B 11.11B 10.43B 19.59B 1,324B 19.78B 131B 51.32B 648B 52.58B 51.47B
Net income 296B 1.85B 1.6B 1.47B 1.38B 2.59B 175B 2.61B 17.36B 6.78B 85.67B 6.95B 6.8B 350B 2.18B 1.88B 1.73B 1.63B 3.05B 206B 3.08B 20.49B 8B 101B 8.2B 8.02B
Net Debt 429B 2.68B 2.31B 2.12B 1.99B 3.74B 253B 3.78B 25.09B 9.8B 124B 10.04B 9.83B -103B -642M -553M -509M -477M -897M -60.64B -906M -6.02B -2.35B -29.7B -2.41B -2.36B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
13,643
Date Price Change Volume
15/06/26 13.38 $ -0.30% 250,873
12/06/26 13.42 $ +1.21% 164,997
11/06/26 13.26 $ +0.38% 359,706
10/06/26 13.21 $ -0.60% 152,342
09/06/26 13.29 $ -1.48% 325,172
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,152.50JPY
Average target price
2,400.00JPY
Spread / Average Target
+11.50%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!